Background: The novel coronavirus disease 2019 (COVID‐19) was more devastating in people with comorbidities such as advanced age and immunodeficiency. Another group affected by COVID‐19 was pregnant women. Immunological changes during pregnancy and conditions such as gestational diabetes and pre‐eclampsia that occur during pregnancy also have effects on the fetus. The aim of this study was to analyze the effects of PCR‐proven COVID‐19 infection during pregnancy on fetus and newborn.Methods: Between December 2019 and October 2021, data from pregnant women with COVID‐19 symptoms or a history of contact with people with COVID‐19, infected with PCR‐proven COVID‐19 virus, were analyzed retrospectively. Clinical and laboratory data of pregnant women were analyzed. Death data associated with COVID‐19 were evaluated. Clinical and laboratory findings of newborns related to COVID‐19 and mortality data related to COVID‐19 were recorded. The study received approval from the Gazi Yasargil Training and Research Hospital ethics committee (09.07.2021/853).Results: We evaluated 327 pregnant women who were followed up in our hospital and whose deliveries ended in live birth, stillbirth, miscarriage, or curettage. One hundred eighty‐five (56.6%) of the pregnant women had at least one COVID‐19‐related symptom. We evaluated the data of 306 live births, 21 intrauterine fetal deaths, and 13 postnatal deaths. Among the postnatal deaths, five infants succumbed directly due to COVID‐19 infection. A total of 23 live‐born babies (7.5%) were classified as small for gestational age (SGA), while 80 babies (26.1%) were born before 37 weeks of gestation, and 32 babies (10.4%) were born before 32 weeks. Cord blood gas analysis revealed that 19 infants (6.3%) had pH < 7 and base excess (BE) < −12. The rate of perinatal asphyxia was significantly higher in babies born to mothers who did not survive (p = 0.027). A considerable number of infants, 119 (40.3%), were admitted to the neonatal intensive care unit (NICU). Among the seven infants with positive PCR results admitted to the NICU, five (4.2%) did not survive.Conclusion: While COVID‐19 infection in pregnancy seriously affects mortality and morbidity in pregnant women, it also causes mortality and morbidity on the fetus.
Background: This study compares short- and mid-term morbidity and mortality outcomes in preterm infants treated with the natural surfactants poractant alfa and calfactant, to assess differences in their clinical efficacy and safety profiles. Methods: In this prospective cohort study, preterm infants (25 0⁄7–32 6⁄7 weeks gestation) admitted to a Level III NICU between January 2023 and March 2024 received either poractant alfa or calfactant according to hospital supply. The primary outcome was moderate-to-severe bronchopulmonary dysplasia (BPD) and/or mortality. Secondary outcomes included extubation success, need for repeat surfactant dosing, and treatment cost per patient. Short- and mid-term morbidity and mortality outcomes were compared between groups. Results: The study included 215 preterm infants (137 in the poractant alfa group; 78 in the calfactant group). Use of less invasive surfactant administration (LISA) and INSURE techniques was significantly higher in the poractant alfa group (32.8% vs. 10.3%; p < 0.01). Poractant alfa was administered earlier, at higher per-kg doses, and at lower median treatment cost. Rates of moderate-to-severe BPD, the composite outcome BPD or mortality, reintubation, duration of respiratory support, and length of hospitalization did not differ significantly between groups. In the poractant alfa group, the need for a second surfactant dose was lower (p = 0.027). Overall mortality was similar (21.2% vs. 24.4%; p = 0.13), with no significant difference in timing of death. Conclusions: Compared with calfactant, poractant alfa offers practical advantages—such as a higher initial dose, lower cost, and reduced need for a second repeat dose—while yielding comparable short- and mid-term morbidity and mortality outcomes.
Background: Cranial Doppler ultrasonography (DS) is a non-invasive method for evaluating cerebral hemodynamics in neonates with perinatal asphyxia (PA). This study aimed to assess whether cerebral vascular resistance indices (RIs) measured within the first 24 h of life can predict the severity of brain injury. Methods: DS was performed on the anterior cerebral artery (ACA) and middle cerebral artery (MCA) between 6 and 24 h after birth in newborns diagnosed with PA. Prognostic value was evaluated by comparing RI values with cranial magnetic resonance imaging (MRI) results. Results: Of the 107 infants included in the study, 11 (10.3%) had severe brain damage, 27 (25.2%) had mild and 20 (18.7%) had moderate changes. The mean ACA RI was 0.61 ± 0.15 in the severe group and 0.70 ± 0.12 in the mild–moderate group (p = 0.023). MCA RI was 0.63 ± 0.20 and 0.71 ± 0.13, respectively. ROC analysis showed an area under the curve (AUC) of 0.901 for ACA RI with a cut-off of 0.58 (84% sensitivity and 84% specificity), and 0.874 for MCA RI with a cut-off of 0.59 (83% sensitivity and 84% specificity). Conclusions: Early ACA and MCA RI measurements via Doppler ultrasonography may serve as valuable predictors of brain injury severity in neonates with PA and should be considered alongside other clinical and imaging findings.
Background/Objectives: Neonatal sepsis remains a major diagnostic challenge, particularly in postoperative infants where systemic inflammatory responses may mimic infection; therefore, reliable biomarkers are urgently needed to distinguish sepsis from normal post-surgical changes. Methods: This prospective cohort study included 135 neonates who underwent surgery without preoperative signs of infection. Serum levels of C-reactive protein (CRP) and procalcitonin (PCT) were measured preoperatively and at 24, 72 and 120 h postoperatively. Patients were classified as having proven sepsis based on positive blood cultures or clinical sepsis using European Medicines Agency (EMA) neonatal sepsis scoring. Biomarker levels were compared between septic and non-septic infants, and diagnostic performance was evaluated using receiver operating characteristic analysis. Results: Sixteen infants had proven sepsis and twenty-five had clinical sepsis. Both CRP and PCT levels showed a significant rise in septic infants at 72 h postoperatively (p < 0.01) and remained elevated at 120 h. PCT demonstrated the highest diagnostic accuracy at 72 h (AUC 0.911; threshold 1.2 µg/L; sensitivity 83%; specificity 84%), while CRP also showed good performance (AUC 0.802–0.838). Conclusions: CRP, PCT and albumin are valuable postoperative sepsis markers; however, single-parameter interpretation is insufficient, and a multiparametric, time-dependent approach provides superior diagnostic reliability in neonatal sepsis.
Özet Amaç: Bu çalışmanın amacı; karın ağrısı ile başvuran çocuklarda cerrahi gereksinimini öngörebilmede platelet kitle indeksinin belirleyiciliğini saptayabilmektir. Materyal ve Metod: 1 Ocak 2024 ile 1 Ocak 2025 tarihleri arasında pediatriye karın ağrısı nedeniyle kabul edilen 3 ay-18 yaş arasındaki çocuk hastaların verileri retrospektif olarak analiz edildi. Hastaların platelet kitle indeksi (PKİ), hemoglobin, hematokrit, lökosit (WBC), nötrofil/lenfosit oranı gibi tam kan sayımı parametreleri cerrahi gereksinimi öngörme gücü açısından değerlendirildi. Bulgular: Toplam 141 pediatrik hastanın verileri analiz edildi. WBC sayısı opere edilenlerde (Grup 2) 15070±5120/mm3 ve diğer hastalarda (Grup 1) ise 10358±4200/mm3 ‘tü (p
Clinical characteristics, antibiotic resistance patterns, and factors associated with mortality in neonatal Serratia marcescens bloodstream infections: a single-center retrospective cohort study - Turkish Journal of Neonatology